Номер	Авторы, название публикации и источника, где она опубликована, выходные данные	ФИО, название публикации и источника на английском
	Полный интернет-адрес 
(URL) цитируемой статьи или ее doi.	
1.		Курочкина Ю.Д., Леплина О.Ю., Тихонова М.А., Тыринова Т.В., Баторов Е.В., Сизиков А.Э., Останин А.А., Черных Е.Р. Влияние дексаметазона на интерферон-α-индуцированную дифференцировку моноцитов в дендритные клетки. Медицинская иммунология. 2016, Т. 18, № 4, С. 347-356.	Kurochkina Y.D., Leplina O.Y., Tikhonova M.A., Tyrinova T.V., Batorov E.V., Sizikov A.E., Ostanin A.A., Chernykh E.R. Effect of dexamethasone on interferon-α-induced differentiation of monocytes to dendritic cells. Medical Immunology (Russia). 2016, Vol. 18, no. 4, pp. 347-356. (In Russ.)	https://doi.org/10.15789/1563-0625-2016-4-347-356	
2.		Тыринова Т.В., Леплина О.Ю., Тихонова М.А., Сахно Л.В., Останин А.А., Черных Е.Р. Характеристика сигнальных путей, опосредующих цитотоксический эффект дендритных клеток против активированных Т-лимфоцитов и NK-клеток. Медицинская иммунология. 2012, Т. 14, № 1-2. С. 43-50.	Tyrinova T.V., Leplina O.Y., Tikhonova M.A., Sakhno L.V., Ostanin A.A., Chernykh E.R. Characteristics of signaling pathways mediating a cytotoxic effect of dendritic cells upon activated т lymphocytes and nk cells. Medical Immunology (Russia). 2012, Vol. 14, no. 1-2, pp. 43-50. (In Russ.)	https://doi.org/10.15789/1563-0625-2012-1-2-43-50	
3.		AmelKashipaz M.R., Huggins M.L., Powell R.J., Todd I. Human autologous mixed lymphocyte reaction as an in vitro model for autoreactivity to apoptotic antigens. Immunology, 2002, Vol. 107, no. 3, pp. 358-365.		doi:  10.1046/j.1365-2567.2002.01516.x	
4.		Bosma B.M., Metselaar H.J.,  Nagtzaam N.M., de Haan R., Mancham S., van der Laan L.J., Kuipers E.J., Kwekkeboom J. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells. Immunology, 2008, Vol. 125, no. 1, pp. 91-100.		doi:  10.1111/j.1365-2567.2008.02824.x	
5.		Calmette J., Ellouze M., Tran T., Karaki S., Ronin E., Capel F., Pallardy M., Bachelerie F., Krzysiek R., Emilie D., Schlecht-Louf G., Godot V. Glucocorticoid- induced leucine zipper enhanced expression in dendritic cells is sufficient to drive regulatory T cells expansion in vivo. J Immunol., 2014, Vol. 193, no.12, pp. 5863-5872.		doi:10.4049/jimmunol.1400758	
6.		Castaneda-Delgado J.E., Bastian-Hernandez Y., Macias-Segura N., Santiago-Algarra D., Castillo-Ortiz J.D., Aleman-Navarro A.L., Martinez-Tejada P., Enciso-Moreno L., Garcia-De Lira Y., Olguin-Calderon D., Trouw L.A., Ramos-Remus C., Enciso-Moreno J.A. Type I interferon gene response is increased in early and established rheumatoid arthritis and correlates with autoantibody production. Front Immunol., 2017, Vol. 20, 8: 285.		doi:  10.3389/fimmu.2017.00285	
7.		Chamorro S., García-Vallejo J.J., Unger W.W., Fernandes R.J., Bruijns S.C., Laban S., Roep B.O., Hart B.A., van Kooyk Y. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J Immunol., 2009, Vol. 183, no.5, pp. 2984-2994.		doi: 10.4049/jimmunol.0801155	
8.		Choy E.H., Kavanaugh A.F., Jones S.A. The problem of choice: current biologic agents and future prospects in RA. Nat. Rev. Rheumatol., 2013, Vol. 9, no. 3, pp. 154-163.		 doi: 10.1038/nrrheum.2013.8	
9.		Dai S., Jia R., Zhang X., Fang Q., Huang L. The PD-1/PD-Ls pathway and autoimmune diseases. Cell Immunol., 2014, Vol. 290, no. 1, pp. 72-79.		doi: 10.1016/j.cellimm.2014.05.006 	
10.		Domogalla M.P., Rostan P.V., Raker V.K., Steinbrink K. Tolerance through education: how tolerogenic dendritic cells shape immunity. Front Immunol., 2017, Vol. 11, 8: 1764.		doi: 10.3389/fimmu.2017.01764. 	
11.		Garcia-Gonzalez P.A., Schinnerling K., Sepulveda-Gutierrez A., Maggi J., Hoyos L., Morales R.A., Mehdi A.M., Nel H.J., Soto L., Pesce B., Molina M.C., Cuchacovich M., Larrondo M.L., Neira O., Catalan D.F., Hilkens C.M., Thomas R., Verdugo R.A., Aguillon J.C. Treatment with dexamethasone and monophosphoryl lipid A removes disease-associated transcriptional signatures in monocyte-derived dendritic cells from rheumatoid arthritis patients and confers tolerogenic features. Front Immunol., 2016, 7: 458.		doi: 
10.3389/fimmu.2016.00458
	
12.		Ge Q., Palliser D., Eisen H.N., Chen J. Homeostatic T cell proliferation in a T cell-dendritic cell coculture system. Proc Natl Acad Sci USA., 2002, Vol. 99, no.5, pp. 2983-2988.		doi: 10.1073/pnas.052714199
	
13.		Gessani S., Conti L., Del Cornò M., Belardelli F. Type I interferons as regulators of human antigen presenting cell functions. Toxins (Basel), 2014, Vol. 6, no. 6, pp. 1696-1723.		doi: 10.3390/toxins6061696.	
14.		Guo Q., Wang Y., Xu D., Nossent J., Pavlos N.J., Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res., 2018, 6: 15.		doi: 10.1038/s41413-018-0016-9. 	
15.		Harry R.A., Anderson A.E., Isaacs J.D., Hilkens C.M. Generation and characterization of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis., 2010, Vol. 69, no. 11, pp. 2042-2050.		doi:  10.1136/ard.2009.126383	
16.		Hilkens C.M., Isaacs J.D. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clin. Exp. Immunol., 2013, Vol.172, no. 2, pp. 148-157.		doi: 10.1111/cei.12038.	
17.		Kimura S., Fujimoto N., Okada H. Impaired autologous mixed-lymphocyte reaction of peripheral blood lymphocytes in adult periodontitis. Infect Immun.,1991, Vol.59, no.12, pp.4418-4424.		PMCID: 259058
	
18.		Kondo T., Cortese I., Markovic-Plese S., Wandinger K.P., Carter C., Brown M., Leitman S., Martin R. Dendritic cells signal T cells in the absence of exogenous antigen. Nat Immunol., 2001, Vol.2, no. 10, pp.932-938.		doi: 10.1038/ni711
	
19.		Leplina O.Y., Tyrinova T.V., Tikhonova M.A., Ostanin A.A., Chernykh E.R. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential. Cytokine., 2015, Vol. 71, no. 1, pp. 1-7.		doi: 10.1016/j.cyto.2014.07.258
	
20.		 Manoharan I., Hong Y., Suryawanshi A.,  Angus-Hill M.L., Sun Z., Mellor A.L., Munn D.H., Manicassamy S.TLR2-dependent activation of β-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammation. J Immunol., 2014, Vol.193, no.8, pp. 4203-4213.		doi:  10.4049/jimmunol.1400614	
21.		Naranjo-Gómez M., Raich-Regue D., Onate C., Grau-Lopez L., Ramo-Tello C., Pujol-Borrell R., Martinez-Caceres E., Borras F.E.. Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med., 2011, 9: 89.		doi:  10.1186/1479-5876-9-89	
22.		Netea M.G., Sutmuller R., Hermann C., Van der Graaf C.A., Van der Meer J.W., van Krieken J.H., Hartung T., Adema G., Kullberg B.J. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol., 2004, Vol.172, no 6, pp. 3712-3718.		doi: 10.4049/jimmunol.172.6.3712	
23.		Osorio F., Fuentes C., Lуpez M.N., Salazar-Onfray F., Gonzalez F.E. Role of dendritic cells in the induction of lymphocyte tolerance. Front Immunol., 2015, 6: 535.		doi: 10.3389/fimmu.2015.00535. 	
24.		Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., Socci C., Di Carlo V. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol., 1999, Vol. 162, no.11,pp. 6473-6481.		PMID: 10352262	
25.		Romain P.L., Schlossman S.F., Reinherz E.L. Surface molecules involved in self-recognition and T cell activation in the autologous mixed lymphocyte reaction. J Immunol., 1984, Vol.133, no. 3, pp. 1093-1100.		PMID: 6235279
	
26.		Sakhno L.V., Tikhonova M.A., Tyrinova T.V., Leplina O.Yu., Shevela E.Ya., Nikonov S.D., Zhdanov O.A., Ostanin A.A., Chernykh E.R. Cytotoxic activity of dendritic cells as a possible mechanism of negative regulation of T lymphocytes in pulmonary tuberculosis. Clin  Dev Immunol., 2012,  Vol. 2012, Article ID 628635.		doi: 10.1155/2012/628635	
27.		Selim A., Yong-Soo B. Dendritic cell-based immunotherapy for rheumatoid arthritis: from bench to bedside. Immune Network, 2016, Vol. 16, no. 1, pp. 44-51.		doi: 10.4110/in.2016.16.1.44	
28.		Stoop J.N., Robinson J.H., Hilkens C.M. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models? Ann Rheum Dis, 2011, Vol. 70, no. 9, pp.1526-1533.		doi: 10.1136/ard.2011.151654.	
29.		Surh C.D., Sprent J.. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J Exp Med., 2000, Vol. 192, no. 4, pp. 9-14.		PMID: 10952731	
30.		Unger W.W., Laban S., Kleijwegt F.S., van der Slik A.R., Roep B.O. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol., 2009, Vol. 39, no. 11, pp. 3147-3159.		doi: 10.1002/eji.200839103.	
31.		Vakkila J., Hurme M. Both dendritic cells and monocytes induce autologous and allogeneic T cells receptive to interleukin 2. Scand J Immunol., 1990, Vol. 31, no. 1, pp. 75-83.		PMID: 2137256
	
32.		Van Duivenvoorde L.M., Han W.G.H., Bakker A.M., Louis-Plence P, Charbonnier L-M, Apparailly F, van der Voort E.I.H., Jorgensen C., Huizinga T.W.J., Toes R.E.M. Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol, 2007, Vol.179, no.3, pp.1506-1515.		doi:10.4049/jimmunol.179.3.1506	
33.		Wagner U., Pierer M., Wahle M., Moritz F., Kaltenhäuser S., Häntzschel H. Ex vivo homeostatic proliferation of CD4+ T cells in rheumatoid arthritis is dysregulated and driven by membrane-anchored TNF-alpha. J Immunol., 2004, Vol. 173, no. 4, pp. 2825-2833.		doi: 10.4049/jimmunol.173.4.2825	
34.		Wampler M.T, Vashisht P., Dorschner J.M., Jensen M.A., Chrabot B.S., Kern M., Curtis J.R., Danila M.I., Cofield S.S., Shadick N., Nigrovic P.A., St Clair E.W., Bingham C.O., Furie R., Robinson W., Genovese M.0, Striebich C.C., O'Dell J.R., Thiele G.M., Moreland L.W., Levesque M., Bridges S.L. Jr, Gregersen P.K., Niewold T.B. Increased pretreatment serum IFN-β/α ratio predicts non-response to tumor necrosis factor α inhibition in rheumatoid arthritis. Ann Rheum Dis, 2016, Vol. 75, no. 10, pp. 1757-1762.		doi: 10.1136/annrheumdis-2015-208001	
35.		Woltman A.M., van der Kooij S.W., de Fijter J.W., van Kooten C. Maturation- resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+ T-cell populations. Am J Transplant., 2006, Vol. 6, no.11, pp. 2580-2591.		doi:10.1111/j.1600-6143.2006.01520.x 42.	
36.		Xia C.Q., Peng R., Beato F., Clare-Salzler M.J. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol., 2005, Vol. 62, no.1, pp. 45-54.		doi: 10.1111/j.1365-3083.2005.01640.x